Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Prograf

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prograf was produced by Astellas.

Astellas: Ten years young

Astellas: Ten years young

diff. Alongside these launches the company has been moving into the oncology arena, adding to its legacy interest in urology from Yamanouchi and Fujisawa, and transplantation, where it has Prograf (tacrolimus)

Research units to close as Astellas restructures

Research units to close as Astellas restructures For fiscal 2012, revenues grew a little under 4 per cent to 1, 000bn yen - driven by immunosupressant Prograf (tacrolimus), Vesicare (solifenacin succinate) for overactive bladder and recently-launched prostate cancer

The birth of Christiaan Barnard – the first man to perform a heart transplant

The birth of Christiaan Barnard – the first man to perform a heart transplant It received US approval in 1983. Since then, even more immunosuppressant products, including Astellas' Prograf (tacrolimus) and Pfizer's Rapamune (sirolimus), have come to the market, improving the post-operative health

Astellas, Medivation prostate cancer drug beats expectations in phase III

Astellas said growth was driven by Vesicare (solifenacin succinate) for overactive bladder and lung cancer drug Tarceva (erlotinib), while immunosuppressant Prograf (tacrolimus) for benign prostatic hyperplasia decreased thanks to generic competition

Result pages: 1 | 2 | 3 | 4 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics